Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #1

    IGV v2 performance much worse than IGV 1.5?

    IGV was the first genome browser I ever used that was snappy enough to allow me to really browse. However something seems to happened around the time v2 was released. Performance might be okay for sometimes, but frequent issues plague me.

    I am running a local copy of IGV on a Win7 (SSD OS drive) box with a i7 quad core and 16 GB of RAM. I am running Java6. I edit the .bat file to set max memory to 7-12 GB.

    Using IGV 1.5.64 I can browse a 20 GB .bam file using the Maize ZmB73 5a genome and it is fast -- just liquid. I have the bam file stored locally on an SSD, so I am sure that helps. But the responsiveness is incredible.

    Using IGV 2 (most recently 2.1.10 and 2.1.12), same data, same genome, same machine, it is a complete dog. I navigate to region and wait minutes for the browser to update. The GUI seems confused when I maximize the window. I feel like the mouse pointer is no longer in register with the buttons and windows. In any case I, for example, click a menu dropdown and expect to wait 15 seconds for a response.

    The computer seems normal -- bunch of other applications open, none of them have any problems. I can't see any limiting resource using the resource monitor.

    I guess I'll stick with 1.5 for the time being but there are some bugs and the feature set is somewhat more limited.

    Anyone else see issues with IGV2 that they do or did not with IGV1.5?

    --
    Phillip
  • Jim Robinson
    Member
    • May 2009
    • 75

    #2
    Hi Philip,

    Sorry for the difficulties. We have had other reports of this, but sporadic. What I need is someone to work with me long enough to isolate the cause, we use it heavily here at the Broad and don't see this.

    For starters having your igv.log file would be helpful, you can send it to [email protected]. If there's nothing helpful in there I can create a special build with more logging statements.

    If you, or someone else with this problem, can work with me for a few iterations I'm confident we can isolate the cause. Its got to be environment related because, again, there's a lot of sequencing happening here and we do not see this problem.

    -- Jim

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    1 view
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Working...